Cargando…
Methylation and expression of PTPN22 in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is a fatal disease contributed by both genetic and epigenetic factors. The epigenetic alteration of protein tyrosine phosphatase non-receptor type 22 (PTPN22) and its clinical significance in ESCC were still not yet clarified. A quantitative methylation stud...
Autores principales: | Deng, Jiaying, Zhang, Junhua, Wang, Chunyu, Wei, Qing, Zhou, Daizhan, Zhao, Kuaile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325424/ https://www.ncbi.nlm.nih.gov/pubmed/27613842 http://dx.doi.org/10.18632/oncotarget.11581 |
Ejemplares similares
-
Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing
por: Deng, Jiaying, et al.
Publicado: (2019) -
A nomogram and risk classification model predicts prognosis in Chinese esophageal squamous cell carcinoma patients
por: Deng, Jiaying, et al.
Publicado: (2022) -
A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence
por: Liu, Qi, et al.
Publicado: (2020) -
Long term results of different radiotherapy techniques and fractions for esophageal squamous cell carcinoma
por: Deng, Jiaying, et al.
Publicado: (2020) -
Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma
por: Deng, Jiaying, et al.
Publicado: (2014)